1. Home
  2. CLGN

CLGN

CollPlant Biotechnologies Ltd

Logo CollPlant Biotechnologies Ltd

Health Care

Industrial Specialties

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Founded: 2004 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 59.6M IPO Year: N/A
Target Price: $11.00 AVG Volume (30 days): 7.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.62 EPS Growth: N/A
52 Week Low/High: $4.22 - $8.90 Next Earning Date: 04-04-2024
Revenue: $10,959,000 Revenue Growth: 3565.22%
Revenue Growth (this year): 103.09% Revenue Growth (next year): 147.19%

Share on Social Networks: